article: Mutations in VCP (Valosin-containing protein), an AAA ATPase critical for ER-associated degradation, are linked to IBMPFD (Inclusion body myopathy with Paget disease and frontotemporal dementia). Using a Drosophila IBMPFD model, we have identified the ER protein Derlin-1 as a modifier of pathogenic TER94 (the fly VCP homolog) mutants. Derlin-1 binds to TER94 directly, and this interaction is essential for Derlin-1 overexpression to suppress the pathogenic TER94-induced neurodegeneration. Derlin-1 overexpression reduces the elevated ATPase activity of pathogenic TER94, implying that IBMPFD is caused by ATPase hyper-activation. Under physiological condition, Derlin-1 expression is increased upon ER stress to recruit TER94 to the ER. However, in response to severe ER stress, Derlin-1 is required for activating apoptosis to eliminate damaged cells. This pro-apoptotic response is mimicked by Derlin-1 overexpression, which elicits acute ER stress and triggers apoptosis via a novel C-terminal motif (α). As this Derlin-1-dependent cell death is negated by TER94 overexpression, we propose that while Derlin-1 and VCP work cooperatively in ER stress response, their imbalance has a role in removing cells suffering prolonged ER stress.
  Valosin-containing protein (VCP), a highly conserved AAA (ATPase associated with various cellular activities) ATPase, has been implicated in proteasomal degradation [1], cell cycle control [2], membrane fusion [3], [4], transcription activation [5], and endoplasmic reticulum (ER) -associated degradation (ERAD) [6], [7]. To achieve this functional plasticity, VCP cooperates with a number of cofactors/adaptors to process specific substrates. For instance, VCP, with p47, promotes Golgi reassembly at the end of mitosis [8], whereas VCP, along with Ufd1/Npl4, expels misfolded protein from the ER [9]. Given its importance in various cellular pathways, it is not surprising that mutations in VCP cause diseases. Indeed, specific mutations in VCP have been linked to IBMPFD (Inclusion body myopathy with Paget disease and frontotemporal dementia), an autosomal dominant, multi-system degenerative disorder [10]. VCP contains two ATPase domains (D1 and D2), preceded by the N-terminal CDC48 and L1 (first linker) domains. These IBMPFD-associated mutations are clustered in the N-terminal portion of VCP, and have not been found in the major ATPase domain D2 [11], suggesting that they are not loss-of-function alleles. In support of this, biochemical studies have shown that IBMPFD-linked VCP mutants still preserves ATPase activity [12]–[14], and we have genetically demonstrated that three of these disease alleles (R155H in CDC48 domain, R191Q in L1 domain, and A232E in L1-D1 junction) are dominant active mutations [15]. A number of mechanisms have been proposed to account for the pathogenesis of IBMPFD. Cultured cells expressing VCPR155H showed an accumulation of misfolded substrates, suggesting that this common disease mutant causes IBMPFD by disrupting ERAD [16]. In transgenic and knock-in mouse models, VCPR155H expression caused an accumulation of autophagosome-associated proteins, implying that impaired autophagy is a cause for IBMPFD [17], [18]. TDP-43 (TAR-DNA-binding protein 43) -containing aggregates have also been linked to VCP disease mutant-induced cytotoxicity [17], [19], although whether the accumulation of these proteinaceous structures is a direct cause of IBMPFD remains unclear [20]. We have established a Drosophila IBMPFD model, in which muscular and neuronal tissue-specific expression of pathogenic TER94 mutants (the fly VCP homolog carrying mutations analogous to those implicated in IBMPFD) caused degeneration [15]. Pathogenic TER94 mutants exhibited elevated ATPase activities [12]–[14], suggesting that depletion of cellular ATP contributes to IBMPFD pathogenesis. As VCP acts in numerous cellular processes, it is possible that VCP mutants cause IBMPFD via multiple distinct mechanisms. Here we show that overexpression of Derlin-1, an interacting partner of VCP in the ERAD pathway, inhibits the elevated ATPase activities of pathogenic TER94 mutants and suppresses the neurodegenerative defects. Der1 family proteins have emerged as an important component of the ERAD pathway. Mammalian Derlin-1 participates in the retrotranslocation of major histocompatibility complex class I protein [21], [22], and Derlin-2 and Derlin-3, two other human paralogs, have been implicated in ERAD [23]. Structural analyses indicate that Derlin-1 spans the ER membrane either four [21], [24], [25] or six [26] times, consistent with the notion that Derlin-1 functions as a channel for substrate passage through the ER membrane [21], [27]–[29]. Both yeast and human Derlin-1 homologs contain the so-called SHP box in their cytosolic C-terminal tails, which bind to respective AAA ATPases [24], [26], [30]. We show that overexpression of Derlin-1 alone impairs ERAD, activates UPR (Unfolded Protein Response), and causes apoptosis. All these Derlin-1 overexpression defects are suppressed by increased TER94 expression, suggesting that an imbalance between Derlin-1 and TER94 levels is detrimental to cells. As Derlin-1 expression is elevated in response to ER stress, we propose that while Derlin-1 participates in the retrotranslocation of misfolded proteins, prolonged ER stress activates the cytotoxic function of Derlin-1 to prevent these damaged cells from harming the organismal health.
  We have reported a Drosophila IBMPFD model, in which targeted expression of TER94 disease mutants in muscle and nervous systems recapitulates pathophysiological features of the disease, causing tissue degeneration, inclusion body formation and learning deficit [15]. Because this ATPase cooperates with various cofactors and adaptor proteins, we selected 11 candidate genes from literatures [6], [31], [32] and asked whether disruption of any of these accessory proteins by RNAi (dsRNA-mediated RNA interference) might alter the cytotoxicity of a strong pathogenic mutant TER94A229E (the homologous mutation of VCPA232E). We took advantage of the fact that GMR>TER94A229E flies (expressing UAS-TER94A229E transgene under the control of the eye-specific GMR-GAL4 driver) showed rough eyes, and the highly organized architecture of Drosophila eye offers an easy and powerful means to detect genetic interactions. Of the RNAi lines tested, knockdown of three genes, namely derlin-1, ufd1, and sip3 (the Drosophila Hrd1 homolog), exhibited more severe phenotypes (Table S1). Knockdown of Ufd1, a cofactor of VCP ATPase [33], was synthetic lethal with TER94A229E. Knockdown of Sip3 and Derlin-1, two ER membrane proteins thought to form a retrotranslocation passage to expel ERAD substrates [27], enhanced the GMR>TER94A229E eye roughness and the underlying photoreceptor degeneration (Figure 1A and 1B). As these proteins are known to interact with VCP in cultured cells [26], [34], [35], these results demonstrate that this Drosophila IBMPFD model is capable of identifying relevant targets. To test whether overexpression of these genes has complementary effect (i. e. suppression) on the phenotype of VCP pathogenic mutant, derlin-1, ufd1, and sip3 cDNAs were overexpressed with GMR-GAL4 and tested for interaction with GMR>TER94A229E. Although ufd1 and sip3 RNAi enhanced GMR>TER94A229E, overexpressing either ufd1 or sip3 had no apparent effect on the rough eye and the underlying photoreceptor degeneration (Figure 1B). In contrast, derlin-1 overexpression completely suppressed TER94A229E-induced eye phenotypes (Figure 1B). Overexpressing derlin-1 also rescued another two disease mutants TER94R152H and TER94R188Q (Figure 1C), demonstrating that elevated Derlin-1 expression counters the adverse effects of different IBMPFD mutants. Furthermore, this rescue of pathogenic TER94 by Derlin-1 does not appear to require Sip3 and Ufd1, as RNAi knockdown of sip3 or ufd1 (Figure S1) showed no effect on the restored GMR>TER94A229E>derlin-1 eyes (Figure 1D). Yeast and mammalian Derlin-1 homologs are known to interact with their corresponding VCP homologs through the SHP box [26], [30]. Likewise, Derlin-1 forms a complex with TER94, as a TER94 band was detected in the hs>derlin-1 (wild-type Derlin-1 driven by a heat shock-inducible GAL4) extracts co-immunoprecipitated (co-IP) with a polyclonal anti-Derlin-1 antiserum (Figure 2A; see Materials and Methods). No TER94 band was seen when Derlin-1 expression was knocked out in a null mutant (derlin-1l (2) SH1964; herein referred as derlin-1null), demonstrating the specificity of the co-IP analysis (Figure 2A). This TER94 band was also present in the co-IP of hs>TER94A229E extracts, suggesting that the pathogenic mutation does not interfere with Derlin-1/TER94 association. Inspection of Drosophila Derlin-1 protein sequence revealed a C-terminal segment with limited similarity to the SHP box (Figure 2B). To ask whether this putative SHP box is responsible for the association of Derlin-1 with TER94, pull-down assays were performed by incubating purified GST-Derlin-1 fusion proteins with fly extract (Figure 2C). While GST alone and the Derlin-1 N-terminal portion were incapable of binding to TER94, the Derlin-1 C-terminal portion was sufficient to pull down both TER94 wild-type (TER94WT) and TER94A229E (Figure 2C and Figure S2A). This binding was abolished without the putative SHP box, suggesting that it facilitates the direct association of Derlin-1 C-terminal portion with TER94 (Figure 2C). To pinpoint the TER94 domains critical for its interaction with Derlin-1 and to test a direct interaction between them, purified His-tagged TER94 fragments were subjected to pull-down assays with GST-Derlin-1 (see Materials and Methods). Similar to the full-length TER94, a truncation with the CDC48 domain and first linker (N-L1) was bound to Derlin-1. In contrast, truncations containing the ATPase domains (D1 and D2) and His alone showed no interaction (Figure 2D). These results demonstrate that the N-terminal portion of TER94 is responsible for interacting directly with Derlin-1. To test whether this direct interaction is essential for the Derlin-1-mediated suppression of GMR>TER94A229E, we generated UAS-derlin-1ΔSHP, which lacks the putative SHP box. Unlike wild-type derlin-1, overexpressing derlin-1ΔSHP failed to suppress GMR>TER94A229E (Figure 2E), demonstrating that this putative SHP box in Derlin-1 is crucial for its physical and functional interactions with VCP. Consistent with this, overexpressing fly Derlin-2, which contains a more divergent SHP box (interrupted by eight amino acids as aligned by ClustalW; Figure 2B) and does not bind to TER94 (Figure S2B), showed no rescue of GMR>TER94A229E (Figure 2E). To ask if the ER association is crucial for Derlin-1 to suppress TER94A229E, we generated transgenic lines expressing Derlin-1 C-terminal cytoplasmic tail (aa. 189∼245; including the SHP box) fused to GFP (GFP-Derlin-1-CT). Unlike wild-type Derlin-1, this N-terminal transmembrane domain-deleted construct failed to suppress TER94A229E (Figure 2E), suggesting that besides interacting directly with TER94A229E, the ER localization of Derlin-1 is critical for suppressing the disease mutant phenotype. We have shown that TER94A229E expression causes defects in the eye morphology and photoreceptor organization by depleting cellular ATP [15]. To correlate this pathogenic phenotype with the enzymatic properties of TER94 mutant, we performed an in-gel assay to directly measure the ATPase activity of TER94A229E. Compared with TER94WT, TER94A229E exhibited a ∼40% increase in ATPase activity (Figure 3A), consistent with the notion that this pathogenic TER94 mutant consumes more ATP in vivo. To understand the mechanism underlying this Derlin-1-mediated suppression, we asked whether Derlin-1 overexpression restores the cellular ATP level in TER94A229E-expressing flies. Compared to the hs>LacZ control, hs>TER94A229E flies exhibited a 25% reduction in the cellular ATP level (Figure 3B). In contrast, flies co-expressing Derlin-1 with TER94A229E had similar ATP level as hs>LacZ (Figure 3B), suggesting that Derlin-1 suppresses TER94A229E defects by restoring the cellular ATP level. As Derlin-1 binds to TER94, Derlin-1 overexpression may affect the elevated ATPase activity of disease mutant directly. To test this, we measured the TER94 activity in different genetic backgrounds. Consistent with the reduced cellular ATP level in TER94A229E-expressing tissue (Figure 3B), enhanced ATPase activity was observed in this disease mutant (Figure 3C). Compared to TER94A229E alone, TER94A229E in the presence of transient Derlin-1 expression showed a ∼40% reduction in its ATPase activity (Figure 3C and 3E). This Derlin-1-dependent reduction of TER94 ATPase activity is not restricted to disease mutant, as a similar inhibition was observed with TER94WT (Figure 3D and 3E). These observations suggest that elevated Derlin-1 expression restores the cellular ATP level in the IBMPFD model by directly inhibiting the mutant TER94 ATPase activity. While the retrotranslocation of model ERAD substrate is defective in cells expressing TER94K2A (a dominant-negative TER94 mutant; Figure 4A) [15], [36], the significance of VCP/Derlin-1 interaction is not fully understood. To investigate whether fly Derlin-1 participates in ERAD, we monitored the signal from CD3δ-YFP, a well-established fluorescent ERAD substrate [15], [37], in eye discs homozygous for derlin-1null. While the CD3δ-YFP signal was absent in control, CD3δ-YFP accumulated around the nuclei in derlin-1null eye disc cells (Figure 4A), indicating that fly Derlin-1, like TER94, is required for ERAD. To understand the role of fly Derlin-1 in maintaining ER homeostasis, we tested whether its expression responds to ER stress. Treating eye discs with dithiothreitol (DTT), a known ER stressor [38], resulted in an increase of endogenous derlin-1 mRNA and protein (Figure 4B and 4C). DTT treatment also elevated the mRNA level of bip, the ER chaperone commonly serves as the hallmark of UPR [39]. To demonstrate that this Derlin-1 response can be elicited by an independent ER stress other than pharmacological treatments, adult flies were treated with a cold shock (two hours at 0°C), which transiently detains secretory proteins in the ER and activates the UPR response as reported by Xbp1-eGFP [40], [41] (Figure S3). Similar to the DTT treatment, Derlin-1 protein level was increased by the cold shock (Figure 4D and 4E). Moreover, induced Derlin-1 partially co-localized with KDEL-eGFP, an ER-marker (Figure 4F). Together, these results demonstrate that Derlin-1 expression responds to ER stress. To ask whether TER94 expression, like Derlin-1, responds to ER stress, we measured the TER94 protein level in flies treated with a cold shock. Quantitative Western analyses showed that the level of endogenous TER94 was not altered by the treatment (Figure S4), although the association of TER94 with the ER was noticeably increased (Figure 4G). This co-localization of TER94 with KDEL-eGFP was reduced by derlin-1 knockdown (Figure 4G), implying that the stress-induced Derlin-1 expression serves to recruit TER94 to the ER. As Derlin-1 knockdown showed a reduced KDEL-eGFP signal, images from four independent experiments were quantified to confirm that the co-localization between TER94 and KDEL was Derlin-1-dependent (Figure 4H). In support of these co-localization studies, co-IP with anti-VCP antibodies showed that the level of Derlin-1/TER94 complexes increased by 4. 9 ± 0. 98 folds (after normalization with TER94 levels) after cold treatment (Figure 4I). All together, these data suggest that coordinated interaction between Derlin-1 and TER94 not only affects the pathogenesis of IBMPFD disease mutant, but also acts in an ER stressed condition. Cells suffering from excessive ER stress are often eliminated by apoptotic cell deaths. As Derlin-1 expression is elicited by ER stress, we hypothesize that Derlin-1 has a role in facilitating the elimination of cells enduring prolonged ER stress. To test this, we asked whether derlin-1 knockdown influences DTT-induced caspase activation. UAS-CD8-PARP-Venus, an effector caspase reporter, was used to detect the cleavage events generated by caspase-3-like (DEVDase) activity [42] in larval eye discs. GMR>CD8-PARP-Venus eye discs treated with DTT for 1 hour exhibited a robust cleaved PARP signal, indicative of caspase activation. In eye discs treated with DTT for 2 to 3. 5 hours, the PARP signal was stronger, demonstrating that the extent of caspase activation is proportional to the duration of ER stress. In both regimens, the PARP signal was significantly reduced with derlin-1 knockdown (Figure 5A and 5B). To further validate the pro-apoptotic function of Derlin-1 and to avoid potential off-target effect from derlin-1 RNAi, we examined caspase activation and performed TUNEL (terminal deoxynucleotidyl transferase-dUTP nick end labeling) analysis in derlin-1null eye discs treated with ER stressor. While wild-type eye discs treated with DTT for two hours displayed extensive signals of cleaved caspase-3 and TUNEL staining, both apoptotic readouts were reduced in derlin-1null eye discs (Figure 5C, 5D and Figure S5). Collectively, these results demonstrate a role for Derlin-1 in ER stress-induced caspase activation. To test whether Derlin-1 overexpression stimulates apoptotic pathway, we expressed Derlin-1 from GMR-GAL4 (GMR>derlin-1) and used UAS-CD8-PARP-Venus to detect the extent of effector caspase activation. At larval stage, GMR>LacZ control and GMR>derlin-1 eye discs showed mostly membrane-bound Venus and few processed anti-PARP staining, likely associate with apoptotic events in normal developmental eye. At the subsequent stages, while GMR>LacZ exhibited no detectable level of cleaved PARP, GMR>derlin-1 pupal and adult eyes contained robust anti-PARP staining (Figure 5E). Similarly, while few cleaved caspase-3 signals were seen in GMR>LacZ, accumulated caspase-3 signals were readily observed in pupal and adult GMR>derlin-1 retinas (Figure 5F). These results indicate that persistent Derlin-1 expression induces caspase activation. Although increasing wild-type Derlin-1 rescued the rough eye phenotypes associated with pathogenic TER94 mutants, GMR>derlin-1 alone, consistent with the result that excess Derlin-1 activates caspase, caused severe eye defects (Figure 6A). The toxic effect of Derlin-1 overexpression is not restricted to the eye development, as ubiquitous Derlin-1 overexpression by hs-GAL4 or act5C-GAL4 (actin promoter-directed GAL4) caused lethality at the mid-pupal stage. Interestingly, GMR>derlin-1 phenotypes were suppressed by co-expressing TER94WT (Figure 6B) and more severe eye phenotypes, including reduced eye size and loss of photoreceptors, could be observed in derlin-1ΔSHP (Figure 6A), suggesting the binding to TER94 affects Derlin-1-induced dominant phenotype. Western analysis showed that the suppression was not due to a reduction in Derlin-1 level upon TER94 co-expression (Figure 6C). Co-expression of TER94A229E also suppressed GMR>derlin-1, suggesting that the pathogenic mutation does not interfere with this TER94/derlin-1 interaction (Figure 1B). Moreover, overexpressing human VCP suppressed GMR>derlin-1 (Figure 6B), suggesting the interaction between these two proteins is evolutionarily conserved. The reciprocal suppression of Derlin-1 and TER94 overexpression suggests that the levels of these proteins under physiological conditions need to be coordinated. Indeed, in sensitized backgrounds like GMR>derlin-1 or GMR>TER94WT, exacerbating the imbalance in Derlin-1 and TER94 levels worsened their phenotypes. For instance, although TER94 heterozygotes were viable, TER94 heterozygotes in GMR>derlin-1 background resulted in lethality (Figure 6B). Conversely, while GMR>TER94WT had no apparent effect by itself in terms of eye roughness and cell loss, eye defect was manifest when it was expressing in derlin-1 heterozygous background (Figure 6B). The cytotoxicity caused by Derlin-1 overexpression may mimic a situation, in which prolonged ER stress induces Derlin-1 expression to an extent that exceeds the level of cytoplasmic TER94. In that scenario, the level of free Derlin-1 (not associated with TER94) would increase as ER stress persists. To demonstrate this, sequential IP (first by VCP antibody and then by Derlin-1 antibody) was performed on adult flies treated with 24 µM tunicamycin (Tm), which has been used to cause ER stress for long duration (Figure 7A) [43]. Under this regimen, Tm-treated flies exhibited a high fatality rate at day 6, and most of them died by day 9. Although Derlin-1 level was elevated throughout the duration of Tm treatment (Figure 7B), the level of Derlin-1 associated with TER94 peaked at day 2 and significantly decreased afterward (Figure 7C). This analysis showed that free Derlin-1 level increased as ER stress persisted (Figure 7C). Together, these correlations support the idea that unbound Derlin-1 causes apoptosis. Excessive Derlin-1, because of its inability to interact with TER94, may interfere with the retrotranslocation of ERAD substrates. To test this, we examined the ERAD and UPR reporters in GMR>derlin-1. A robust CD3δ-YFP signal was seen in GMR>derlin-1 eye discs, although the pattern differed from those seen in derlin-1null, as the ERAD reporter localized mainly to solid or ring-shaped puncta (Figure 8A). This abnormal CD3δ-YFP pattern suggests that Derlin-1 overexpression perturbs both the ERAD and the ER morphology. In addition, strong Xbp1-eGFP signals were detected in GMR>derlin-1 eye discs, indicative of UPR activation (Figure 8B). Like other GMR>derlin-1 phenotypes, the aberrant CD3δ-YFP accumulation and the Xbp1-eGFP signal were suppressed by TER94WT or TER94A229E overexpression (Figure 8A and 8B). As the abnormal CD3δ-YFP pattern suggests a defect in the ER structures, cells overexpressing Derlin-1 from Rh1>derlin-1 (Rh1-GAL4; UAS-Derlin-1) eyes were analyzed by TEM. Rh1-GAL4, active in the outer photoreceptors, was chosen for this analysis because in the same specimen, the structure of inner photoreceptor (where Rh1 promoter is not active) served as the internal control. As shown in Figure 8, the cytosol of Rh1>derlin-1 outer photoreceptors was often filled with ER-resembling tubular membranes (compare Figure 8C to 8D). This apparent ER expansion is consistent with the structural modification in cells under ER stress [44]. In addition, mitochondria with less than half of size as compared with Rh1>LacZ control were readily seen in Rh1>derlin-1 outer photoreceptors (compare Figure 8C to 8E, and quantified in 8G). Some of these atypical mitochondria showed poor membrane integrity (Figure 8E, red arrowhead) and intracristal swelling (Figure 8E, white arrowheads), suggestive of apoptotic events [45]. The mitochondria in the inner photoreceptors appeared normal (Figure 8F, outlined in yellow; quantified in Figure 8H), indicating that the effect of Derlin-1 overexpression on mitochondrial morphology is cell–autonomous. As excessive Derlin-1 induces mitochondrial abnormality, the cytotoxicity associated with Derlin-1 overexpression may be caused by damaged mitochondria to activate the canonical apoptotic pathway [46]. To confirm that Derlin-1-induced cytotoxicity requires caspase activation, we knocked down seven caspases in fly genome individually and tested their ability to alter the severity of GMR>derlin-1 eye degeneration. While reduction of drice, dcp1, dream, dredd, and damm by RNAi lines or loss-of-function alleles showed no significant interaction, knockdown of decay and dronc, orthologs of effector caspase and caspase-9 respectively, suppressed the photoreceptor degeneration of GMR>derlin-1 (Figure 9A and 9B). Since the activation of caspase-9 and the downstream effector caspase link to mitochondrial disruption, these data support that Derlin-1 overexpression activates intrinsic mitochondrial apoptosis. Before the Derlin-1 antibody was available, we made transgenic flies carrying C-terminally FLAG-tagged Derlin-1 (UAS-derlin-1-FLAG) to monitor its expression and localization. This FLAG-tagged derlin-1 rescued derlin-1null lethality and suppressed GMR>TER94A229E eye phenotype (Figure 10A), demonstrating that the chimera is functional. However, unlike GMR>derlin-1, a comparable level of Derlin-1-FLAG did not cause abnormal eye morphology (Figure 10B and Figure S6A). Similar results were obtained with Derlin-1-Myc (C-terminally Myc-tagged Derlin-1), albeit at a lower expression level (Figure S6A), indicating that this effect is not epitope specific (Figure 10A and 10B). Thus, it appears that the addition of epitope at the C-terminus of Derlin-1 abolishes its overexpression-dependent cytotoxicity. Structural modeling [47] suggested that all these Derlin-1 constructs were predicted to contain six major α-helical segments, corresponding to the proposed transmembrane domains of human Derlin-1 [26] (Figure 10C). However, the untagged Derlin-1 was predicted to contain another α-helix near its C-terminus (compare Figure 10D to 10E and 10F; aa. 201–215, hereby referred to as the α-domain), and it is possible that appending epitopes at the C-terminus disrupts this α-domain. To experimentally validate the significance of this putative α-domain, we generated UAS-derlin-1α (a truncation without the α-domain). As the SHP box remains intact in Derlin-1α, expressing derlin-1α still suppressed GMR>TER94A229E-induced eye phenotype (Figure 10A). However, unlike GMR>derlin-1, GMR>derlin-1α eyes were normal and did not induce ER stress (Figure 10B and Figure S6B), supporting the notion that α-domain is critical for Derlin-1-mediated toxicity. To avoid the complication that this C-terminal deletion broadly disrupts Derlin-1 conformation, we used structure prediction to look for residues that might be crucial for α-domain integrity. Substitution of leucine-204 by glycine (Derlin-1L204G) was predicted to disrupt α-domain (Figure 10G). Western analysis showed that the level of Derlin-1 expressions of wild-type and L204G constructs were comparable (Figure S6A). Similar to derlin-1α, derlin-1L204G suppressed GMR>TER94A229E eye phenotype (Figure 10A), but on its own showed normal eye morphology and no ER stress (Figure 10B and Figure S6B). Together, these data demonstrate that the C-terminal α-domain is not crucial for the suppression of pathogenic TER94, but required for Derlin-1-mediated cytotoxicity.
  The genetic link between VCP missense mutations and a hereditary disorder, first discovered in IBMPFD, has recently been extended to other degenerative diseases, although the underlying pathogenic mechanism remains elusive. Here, we have identified Derlin-1 as a potent modifier of pathogenic TER94 mutant in a Drosophila IBMPFD model. Reduction and overexpression of Derlin-1 both exhibited genetic interactions with the disease-linked TER94 alleles, indicating that the disease pathogenesis is sensitive to Derlin-1 level. Our co-IP and pull-down assays demonstrated that Derlin-1 forms a complex with TER94 in vivo. The region required for this interaction is mapped to a putative SHP box near the C-terminal cytoplasmic tail. More importantly, we provided genetic evidence to show that the integrity of this SHP box, hence the ability to interact with TER94, is essential for the ability of Derlin-1 overexpression to suppress pathogenic TER94 mutants. IBMPFD-linked alleles, like TER94A229E, retain ATPase activity and do not impair ERAD [13], [15], [36], implying that chronic ER stress is not the cause for this disease. We have shown that TER94A229E depletes cellular ATP level and TER94A229E-associated photoreceptor degeneration can be suppressed by restoration of cellular ATP through genetic or environmental means [15]. Our observation that Derlin-1 overexpression restores the cellular ATP level, along with suppressing other TER94A229E-associated defects, further strengthens the notion that chronic ATP depletion results in IBMPFD-like symptoms. VCP/p97 carrying A232E mutation (analogous to TER94A229E) has been proposed to adopt a more mobile conformation with a higher ATPase activity [14]. It is possible that excessive Derlin-1 proteins in the ER (caused by the overexpression) keep TER94A229E in a less mobile conformation, thereby negating the ATP-depleting effect of the disease mutant. Indeed, the ATPase activity of TER94A229E is reduced in the presence of Derlin-1 overexpression. Collectively, these results suggest that excess Derlin-1 reduces TER94 ATPase activity by directly binding to TER94. Alternatively, as VCP has been implicated in multiple processes, TER94 overexpression may cause cytotoxicity via a mechanism unrelated to ATP expenditure. TER94 overexpression, in the absence of Derlin-1 overexpression, generates excessive TER94 in the cytoplasm, which may titrate out a cytoplasmic factor critical for cell survival. Indeed, expression of pathogenic VCP in other models has been shown to cause cytosolic accumulation of autophagosome-associated proteins [17], [18] and TDP-43 [17], [19]. In this scenario, overexpressed Derlin-1 may negate this titration by restricting TER94 to the ER, thereby suppressing TER94-associated phenotypes. In support of this, the Derlin-1 deletion that cannot localize to the ER fails to suppress GMR>TER94A229E. Consistent with the notion that Derlin-1 acts in the retrotranslocation [21], [22], [26], [48]–[51], misfolded proteins accumulate in the ER in derlin-1null mutants, indicative of disrupted ERAD. The fact that loss of Derlin-1 function in both fly and mouse [52] results in lethality suggests that the maintenance of ER homeostasis is critical for animal survival. Derlin-1 expression is elevated in cells treated with DTT, Tm, or cold temperature, suggesting that Derlin-1 is a part of the adaptive program to alleviate ER stress. This response is evolutionarily conserved, as chemical-induced ER stress in yeast also elevates DER1 level [53]. Interestingly, cold treatment does not increase TER94 expression, although the association of TER94 with the ER appears elevated in a Derlin-1-dependent manner. These observations suggest that in the absence of ER stress, Derlin-1 and its associated retrotranslocation machinery (i. e. TER94/Derlin-1 complex) is limited. In response to ER stress, additional Derlin-1 is synthesized and complexes with existent TER94 to restore ER homeostasis. While the function of VCP in ERAD pathway is firmly established, it is unclear how this versatile AAA ATPase is recruited to the ER to process misfolded substrates [35]. The observation that the association of TER94 with the ER is Derlin-1-dependent suggests that Derlin-1 acts as a recruiting factor. This notion is consistent with the fact that mammalian VCP binding to Derlin-1 is required for efficient dislocation of ERAD substrates [26]. As VCP has multiple functions, a tight control of the recruiting co-factor expression could ensure the ATPase is utilized efficiently. Given the importance of Derlin-1 in ERAD and its upregulation upon ER stress, why does overexpression of Derlin-1, a component of the machinery responsible for restoring ER homeostasis, cause ER stress and activate pro-apoptotic signals? GMR>derlin-1 defects are suppressed by co-expressing TER94 and exacerbated by reduction of TER94 function, suggesting that it is not the Derlin-1 overexpression per se, but the imbalance between Derlin-1 and TER94 levels that causes ER stress and cell death. As ER stress induces Derlin-1 expression, but not TER94, it is possible that Derlin-1 has another function in addition to maintaining ER homeostasis, depending of the availability of cytoplasmic TER94. In the event of moderate ER stress, the level of cytoplasmic TER94 remains in excess and Derlin-1 induced by low level of ER stress would recruit TER94 to the ER to retrotranslocate misfolded proteins. In the event of severe or chronic ER stress, induced Derlin-1 expression may exceed TER94 level, which would result in a population of Derlin-1 not bound to TER94. Unlike the Derlin-1/TER94 complexes that act to restore ER homeostasis, the unbound Derlin-1 would worsen the ER stress, ensuring the initiation of pro-apoptotic signals. As ER stress-induced UPR needs to juggle between the cyto-protective and pro-apoptotic functions in response to ER stress, the level of unbound Derlin-1 may act as a sensor of cells with irreparable ER stress. In support of this, we show that while Tm treatment initially enhances Derlin-1/TER94 association, the level of unbound Derlin-1 increases in cells with prolonged ER stress. Furthermore, this hypothesis predicts that overexpression of a Derlin-1 mutant incapable of binding to TER94 should enhance the cytotoxicity, which is exactly what we observed with GMR>derlin-1SHP. While it is unclear whether the proposed mechanism exists in other systems, a genome-wide expression analysis in yeast has revealed that UPR up-regulates Der1, but not CDC48 [53]. Although the exact mechanism of how excessive Derlin-1 induces UPR and apoptosis remains enigmatic, we provide evidence that it relies on a novel C-terminal motif. It may be that this α-domain facilitates the interaction of Derlin-1 with another retrotranslocation factor, and this complex acts as a dominant negative without TER94 bound. Alternatively, this α-domain may have an active role in disrupting ERAD, and the binding of TER94 to the SHP motif (adjacent to the α-domain) prevents this α-domain from being exposed. Identifying factors interacting with this α-domain will be needed to define the mechanism for this Derlin-1 overexpression-dependent cytotoxicity.
  Flies were raised on standard cornmeal food at 22°C in 12 hrs light/dark cycles unless otherwise noted. The derlin-1l (2) SH1964, UAS-Lys-GFP-KDEL [54] and UAS-tub-GAL80ts, and all transgenic RNAi lines were obtained from Szeged Drosophila Stock Center (Hungary), Bloomington Stock Center (Indiana, USA), or Vienna Drosophila RNAi Center (Austria), respectively. UAS-xbp1-eGFP and UAS-CD8-PARP-Venus were generous gifts from Drs. Hermann Steller and Darren Williams. UAS-CD3δ-YFP, GMR-GAL4, Rh1-GAL4, hs-GAL4, and dammf022091 flies have been previously described [15], [55]. To construct pUAST-derlin-1, pUAST-sip3, and pUAST-ufd1, Drosophila derlin-1 (GH08782), Sip3 cDNA (GH11117), and Ufd1 (GH18603) cDNA clones were obtained from Drosophila Genomics Resource Center (Indiana, USA), and subcloned into pUAST as EcoRI-XhoI fragments. To construct pUAST-GFP-Derlin-1-CT, Derlin-1 cytoplasmic tail (corresponding to aa. 189–245) was PCR amplified (F, 5′GAGCGGCCGCTAATTCGCAGGA3′; R, 5′GCGCTCGAGTTCAGTTGCGACCC3′) and cloned into pUAST-GFP as a NotI-XhoI fragment, resulting in an in-frame fusion to the C-terminus of GFP. To generate tagged derlin-1 constructs, FLAG or Myc sequences were appended in frame to the C-terminus of derlin-1 by PCR. Derlin-1 deletion and point mutation variants were generated by PCR or site-directed mutagenesis (QuikChange, Stratagene). For pUAST-derlin-2 construct, a set of primers were designed (see Table S2) to amplify the full-length derlin-2 cDNA by RT-PCR (below) of wild-type fly RNA, and subsequently cloned into pUAST as EcoRI-XhoI fragments. For pUAS-caspase RNAi constructs, 22 nt sequences corresponding to mature Mir 6. 1 were replaced with sequences perfectly complementary to the coding sequences of the caspase [56]. The targeted sites are listed in Table S2. All constructs were verified by sequencing, and transgenic flies were generated by P element-mediated transformation. For RT-PCR, 2 µg of total RNA, isolated with the TRIzol reagent (Invitrogen), was used for reverse transcription (SuperScript II, Invitrogen). Primer sets and conditions for subsequent PCR amplification are listed in Table S2. To generate polyclonal anti-Derlin-1 antibody, a peptide (N-SRAPPRQATESPWG-C) corresponding to the C-terminus of Derlin-1 was synthesized and used for immunization (GenedireX, Taiwan). In Western analysis, this antibody detected a prominent ∼27 kD band in control extract, correlating well with the predicted molecular mass of Derlin-1 protein (28. 25 kD). This antibody is specific, as the intensity of this 27 kD band was elevated in hs>derlin-1 and absent in derlin-1l (2) SH1964 extracts. Whole-mount preparation of fly eyes was performed as previously described [57]. The primary antibodies used were anti-Derlin-1 (1∶50), anti-VCP (1∶50, GeneTex, Taiwan), anti-Elav (1∶50, Developmental Studies Hybridoma Bank, DSHB), anti-LaminDm (1∶20, DSHB), anti-cleaved PARP (1∶50, abcam), and anti-cleaved caspase-3 (1∶50, Cell Signaling). For TUNEL staining, eyes were dissected in PBS and then treated with fresh prepared DTT. Samples were fixed and permeabilized according to the manufacture' s instruction (ApopTag Red, Millipore). Fluorescently conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) were used at 1∶100 dilutions. Rhodamine-conjugated phalloidin (Sigma) were used (10 µM) to label F-Actin-enriched rhabdomeres. All fluorescent images were collected on Zeiss LSM-510 or 710 confocal microscopes, and processed with Photoshop CS. To compare fluorescent-labeled signals, samples of different genotypes were prepared and imaged with identical procedures and confocal settings. For quantifying co-localization with KDEL-eGFP, Pearson' s co-localization coefficient (PCC) analyses were performed using the NIH ImageJ Just Another Colocalization Plugin (JACoP). JACoP directly provides the PCC values for a set of images in the red and green channels, ranging from 1 for perfectly correlation to -1 for inversely correlation (a PCC value of 0 indicates no correlation between the two channels). The provided PCC values are independent of the fluorescence intensity. For GST pull-down assays, various Derlin-1 C-terminal regions were amplified by PCR, and subcloned into the pGEX-6p3 vector as EcoRI-XhoI fragments. To generate His-TER94 constructs, TER94 fragments were amplified by PCR, and subcloned into pET-28a (+) using EcoRI-XhoI sites. Sequences of the primers used can be found in Table S2. To produce GST- and His-fusion proteins, BL21 cells carrying appropriate plasmids were grown at 37°C, induced with 0. 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG), pelleted, and resuspended in protein extraction buffer (1% CHAPS, 100 mM KCl, 0. 1 M Tris-HCl (pH 7. 5), 20 mM Hepes, 10 mM EDTA, 5% Glycerol) supplemented with protease inhibitor cocktail (Roche). The fusion proteins were purified with MagneGST or MagneHis Protein Purification System kits (Promega) according to manufacturer' s instructions. For the pull-down, immobilized GST-fusion proteins were incubated with either purified His-TER94 or fly protein extracts at 4°C overnight. After washing, bound proteins were eluted and analyzed by Western blots. For immunoprecipitations, transgenic flies driven by hs-GAL4; tub-GAL80ts were treated with three cycles of heat shock (one hour at 37°C followed by one hour at 25°C) to induce transgene expressions. Whole fly protein lysates were collected. Anti-Derlin-1 antibody was bound to protein A-agarose beads (Sigma) by incubation for 4 hours at 4°C, followed by three washes with lysis buffer (0. 5% Triton X-100,10 mM Tris-HCl, 5 mM EDTA, 100 mM NaCl, pH 7. 5). The antibody/agarose beads were then incubated with pre-cleared lysate at 4°C overnight, washed four times with lysis buffer, and eluted by Laemmli buffer for Western analysis. For TER94 co-IP after the cold treatment, wild-type flies were kept at 0°C for two hours, allowed to recover for four hours at 25°C, and then subjected to lysate preparation. For sequential IP, protein lysates from flies fed with 24 µM tunicamycin were subjected to one round of IP using anti-VCP-bound protein A-agarose beads. After incubation for 4 hours at 4°C and centrifugation, the unbound supernatants were subjected to a second round of IP using anti-Derlin-1-bound protein A-agarose beads. Anti-VCP antibody (GeneTex, Taiwan) was used for immunoprecipitation. The primary antibodies were used at the following dilutions: anti-VCP (1∶1000, Cell Signaling), anti-β-Tubulin (1∶10000, DSHB), anti-Derlin-1 (1∶2000), anti-β-Actin (1∶5000, abcam), anti-6XHis (1∶3000, GeneTex), anti-Ufd1 (1∶10000, GeneTex), and anti-GST (1∶50000, Cell Signaling). HRP-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) were used at 1∶10000 dilutions. For immunoblotting after immunoprecipitation, the Clean-Blot IP detection kit (Thermo) was used. ImageJ was used to quantify the immunoblots. Cellular ATP measurements were performed as previously described [15]. ATPase activity analysis was performed as previously described with modifications [58]. Briefly, hs-GAL4; tub-GAL80ts flies were treated as above to induce transgene expressions. Flies were then homogenized in grinding buffer (50 mM NaCl, 50 mM Imidazole/HCl, 2 mM 6-aminohexanoic acid, 1 mM EDTA, 5% Glycerol, pH 7. 0, supplemented with 1% digitonin and protease inhibitor (Roche) ), and the lysates were centrifuged at 16,000xg for 10 min at 4°C to remove cell debris. 80 µg of proteins were loaded onto 7. 5% clear-native PAGE with the addition of 0. 1% Ponceau S to mark the sample front during electrophoresis (45 volts/30 min followed by 100 volts/20 min and then 250 volts/2 hrs at 4°C). The gels were then washed in 35 mM Tris, 270 mM Glycine, pH 8. 3 for 2 hrs at 25°C and then incubated in ATPase assay buffer (35 mM Tris, 270 mM Glycine, 14 mM MgSO4,0. 2% Pb (NO3) 2,8 mM ATP, pH 8. 3) at 25°C overnight. ATP hydrolysis caused lead phosphate to form white precipitates, which turned into brownish-black color after treatment with 1% ammonium sulfide. Quantification of band intensities in photographed gels was analyzed with ImageJ (NIH Image). Scanning electron micrographs of adult eyes were obtained with TM-1000 SEM (Hitachi) as previously described [15]. For transmission electron microscopy, samples and ultrathin sections were prepared as previously described [59], and imaged with HT7700 TEM (Hitachi).
summary: We have previously developed a fly model for IBMPFD (inclusion body myopathy with Paget disease and frontotemporal dementia) and demonstrated that specific mutations in VCP gene, a highly conserved ATPase, cause muscle and neuron degeneration by depleting cellular ATP level. Using this model, we show that expression of Derlin-1, an ER membrane protein capable of directly interacting with VCP, restores the normal cellular ATP level and suppresses IBMPFD-like neurodegeneration. As Derlin-1 expression can be induced by tunicamycin (an antibiotic) in experimental systems, our findings may yield new therapeutic strategies for VCP-linked diseases. In addition, we have obtained important insights regarding Derlin-1 function under physiological conditions. ER stress, caused by accumulation of improperly folded proteins, results in increased Derlin-1 expression, which is important for ER stress-induced cell death. We propose that Derlin-1 promotes ER homeostasis through multiple mechanisms. In addition to cooperating with VCP to extract improperly folded proteins from the ER, elevated Derlin-1 expression removes cells suffering from irreparable ER stress, thus preventing these damaged cells from further harming the organisms.
keywords: medicine and health sciences
  clinical medicine
  cell biology
  pathology and laboratory medicine
  physiology
  neurology
  genetics
  biology and life sciences
  neuroscience
  molecular biology
title: Derlin-1 Regulates Mutant VCP-Linked Pathogenesis and Endoplasmic Reticulum Stress-Induced Apoptosis